Michael J. Wagner, MD

Clinical Research Director
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Presentation(s):

• Paper 12 - INTEGRATED EFFICACY AND SAFETY ANALYSIS OF LETETRESGENE AUTOLEUCEL, A T-CELL RECEPTOR T-CELL THERAPY, ACROSS CLINICAL TRIALS OF PATIENTS WITH SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.

• Paper 17 - DECIPHERING THE IMMUNE MICROENVIRONMENT OF ANGIOSARCOMA: A MULTIMODAL ANALYSIS

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.